In the last 12 months, insiders at Bicara Therapeutics Inc. ($BCAX) filed 206 transactions with the SEC: 6 open-market purchases totaling $39,054,016 and 52 sales totaling $9,708,342. Net insider sentiment: net buying.
Bicara Therapeutics Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- RA CAPITAL MANAGEMENT, L.P. (Not found) — 12 transactions totaling $37,794,016
- Mazumdar Claire (Chief Executive Officer) — 36 transactions totaling $3,567,828
- Meisner Lara (Chief Legal Officer) — 17 transactions totaling $2,783,213
- Cohlhepp Ryan (President and COO) — 37 transactions totaling $2,711,115
- Hyep Ivan (Chief Financial Officer) — 36 transactions totaling $2,033,839
View all SEC Filings for Bicara Therapeutics Inc. (BCAX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | Raben David | Chief Medical Officer | M | Stock Option (Right to Buy) | 5500 | $0.00 | 47,413.0000 | 54,563,864 | 10.39% | 0.01% |
| March 25, 2026 | Raben David | Chief Medical Officer | M | Common Stock | 5500 | $3.79 | 60,786.0000 | 54,563,864 | 9.95% | 0.01% |
| March 25, 2026 | Raben David | Chief Medical Officer | S | Common Stock | 5500 | $18.95 | 55,286.0000 | 54,563,864 | 9.05% | 0.01% |
| March 23, 2026 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 9200 | $18.52 | 145,355.0000 | 54,563,864 | 5.95% | 0.02% |
| March 23, 2026 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 9200 | $3.79 | 154,555.0000 | 54,563,864 | 6.33% | 0.02% |
| March 23, 2026 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 9200 | $0.00 | 48,944.0000 | 54,563,864 | 15.82% | 0.02% |
| March 18, 2026 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 6499 | $0.00 | 184,608.0000 | 54,563,864 | 3.40% | 0.01% |
| March 20, 2026 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 1596 | $0.00 | 176,107.0000 | 54,563,864 | 0.90% | 0.00% |
| March 19, 2026 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 6905 | $18.78 | 339,392.0000 | 54,563,864 | 1.99% | 0.01% |
| March 20, 2026 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 1596 | $3.79 | 340,988.0000 | 54,563,864 | 0.47% | 0.00% |
| March 20, 2026 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 1596 | $18.95 | 339,392.0000 | 54,563,864 | 0.47% | 0.00% |
| March 19, 2026 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 6905 | $0.00 | 177,703.0000 | 54,563,864 | 3.74% | 0.01% |
| March 18, 2026 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 6499 | $3.79 | 345,891.0000 | 54,563,864 | 1.91% | 0.01% |
| March 18, 2026 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 6499 | $18.84 | 339,392.0000 | 54,563,864 | 1.88% | 0.01% |
| March 19, 2026 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 6905 | $3.79 | 346,297.0000 | 54,563,864 | 2.03% | 0.01% |
| March 16, 2026 | Cohlhepp Ryan | President and COO | S | Common Stock | 8000 | $19.66 | 205,141.0000 | 54,563,864 | 3.75% | 0.01% |
| March 16, 2026 | Cohlhepp Ryan | President and COO | M | Common Stock | 8000 | $3.79 | 213,141.0000 | 54,563,864 | 3.90% | 0.01% |
| March 16, 2026 | Cohlhepp Ryan | President and COO | S | Common Stock | 4500 | $19.66 | 200,641.0000 | 54,563,864 | 2.19% | 0.01% |
| March 16, 2026 | Cohlhepp Ryan | President and COO | M | Stock Option (Right to Buy) | 8000 | $0.00 | 117,334.0000 | 54,563,864 | 6.38% | 0.01% |
| March 9, 2026 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 36766 | $3.79 | 376,158.0000 | 54,563,864 | 10.83% | 0.07% |
| March 9, 2026 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 36766 | $0.00 | 191,107.0000 | 54,563,864 | 16.13% | 0.07% |
| March 9, 2026 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 36766 | $19.17 | 339,392.0000 | 54,563,864 | 9.77% | 0.07% |
| March 4, 2026 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 2631 | $3.79 | 342,023.0000 | 54,563,864 | 0.78% | 0.00% |
| March 4, 2026 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 2631 | $0.00 | 233,476.0000 | 54,563,864 | 1.11% | 0.00% |
| March 6, 2026 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 3817 | $18.75 | 339,392.0000 | 54,563,864 | 1.11% | 0.01% |
| March 6, 2026 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 3817 | $3.79 | 343,209.0000 | 54,563,864 | 1.12% | 0.01% |
| March 5, 2026 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 1786 | $18.74 | 339,392.0000 | 54,563,864 | 0.52% | 0.00% |
| March 5, 2026 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 1786 | $3.79 | 341,178.0000 | 54,563,864 | 0.53% | 0.00% |
| March 4, 2026 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 2631 | $18.73 | 339,392.0000 | 54,563,864 | 0.77% | 0.00% |
| March 5, 2026 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 1786 | $0.00 | 231,690.0000 | 54,563,864 | 0.76% | 0.00% |
| March 6, 2026 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 3817 | $0.00 | 227,873.0000 | 54,563,864 | 1.65% | 0.01% |
| March 3, 2026 | Cohlhepp Ryan | President and COO | M | Common Stock | 12892 | $3.79 | 222,533.0000 | 54,563,864 | 6.15% | 0.02% |
| March 4, 2026 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 2963 | $0.00 | 79,784.0000 | 54,563,864 | 3.58% | 0.01% |
| March 3, 2026 | Raben David | Chief Medical Officer | M | Common Stock | 200 | $3.79 | 55,486.0000 | 54,563,864 | 0.36% | 0.00% |
| March 3, 2026 | Raben David | Chief Medical Officer | S | Common Stock | 200 | $18.45 | 55,286.0000 | 54,563,864 | 0.36% | 0.00% |
| March 4, 2026 | Raben David | Chief Medical Officer | M | Common Stock | 16300 | $3.79 | 71,586.0000 | 54,563,864 | 29.48% | 0.03% |
| March 4, 2026 | Raben David | Chief Medical Officer | S | Common Stock | 16300 | $18.52 | 55,286.0000 | 54,563,864 | 22.77% | 0.03% |
| March 3, 2026 | Cohlhepp Ryan | President and COO | S | Common Stock | 12892 | $18.16 | 209,641.0000 | 54,563,864 | 5.79% | 0.02% |
| March 3, 2026 | Cohlhepp Ryan | President and COO | S | Common Stock | 4500 | $18.16 | 205,141.0000 | 54,563,864 | 2.15% | 0.01% |
| March 3, 2026 | Cohlhepp Ryan | President and COO | M | Stock Option (Right to Buy) | 12892 | $0.00 | 125,334.0000 | 54,563,864 | 9.33% | 0.02% |
| March 3, 2026 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 7318 | $3.79 | 152,673.0000 | 54,563,864 | 5.03% | 0.01% |
| March 3, 2026 | Raben David | Chief Medical Officer | M | Stock Option (Right to Buy) | 200 | $0.00 | 69,213.0000 | 54,563,864 | 0.29% | 0.00% |
| March 4, 2026 | Raben David | Chief Medical Officer | M | Stock Option (Right to Buy) | 16300 | $0.00 | 52,913.0000 | 54,563,864 | 23.55% | 0.03% |
| March 3, 2026 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 6237 | $3.79 | 158,910.0000 | 54,563,864 | 4.09% | 0.01% |
| March 3, 2026 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 13555 | $18.22 | 145,355.0000 | 54,563,864 | 8.53% | 0.02% |
| March 4, 2026 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 2963 | $3.79 | 148,318.0000 | 54,563,864 | 2.04% | 0.01% |
| March 4, 2026 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 2963 | $18.25 | 145,355.0000 | 54,563,864 | 2.00% | 0.01% |
| March 3, 2026 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 7318 | $0.00 | 58,144.0000 | 54,563,864 | 11.18% | 0.01% |
| March 3, 2026 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 6237 | $0.00 | 82,747.0000 | 54,563,864 | 7.01% | 0.01% |
| Feb. 26, 2026 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 300000 | $16.00 | 7,255,993.0000 | 54,563,864 | 4.31% | 0.55% |
| Feb. 26, 2026 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Pre-Funded Warrant (Right to Buy) | 2200000 | $16.00 | 2,200,000.0000 | 54,563,864 | 9999.99% | 4.03% |
| Feb. 25, 2026 | Cohlhepp Ryan | President and COO | M | Stock Option (Right to Buy) | 3108 | $0.00 | 138,226.0000 | 54,563,864 | 2.20% | 0.01% |
| Feb. 25, 2026 | Cohlhepp Ryan | President and COO | S | Common Stock | 523 | $18.04 | 209,641.0000 | 54,563,864 | 0.25% | 0.00% |
| Feb. 25, 2026 | Cohlhepp Ryan | President and COO | S | Common Stock | 3108 | $18.04 | 210,164.0000 | 54,563,864 | 1.46% | 0.01% |
| Feb. 25, 2026 | Cohlhepp Ryan | President and COO | M | Common Stock | 3108 | $3.79 | 213,272.0000 | 54,563,864 | 1.48% | 0.01% |
| Feb. 2, 2026 | Raben David | Chief Medical Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 54,563,864 | 9999.99% | 0.18% |
| Feb. 2, 2026 | Meisner Lara | Chief Legal Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 54,563,864 | 9999.99% | 0.16% |
| Feb. 2, 2026 | Hyep Ivan | Chief Financial Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 54,563,864 | 9999.99% | 0.23% |
| Feb. 2, 2026 | Mazumdar Claire | Chief Executive Officer | A | Stock Option (Right to Buy) | 450000 | $0.00 | 450,000.0000 | 54,563,864 | 9999.99% | 0.82% |
| Feb. 2, 2026 | Cohlhepp Ryan | President and COO | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 54,563,864 | 9999.99% | 0.55% |
| Jan. 22, 2026 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 1882 | $0.00 | 65,462.0000 | 54,563,864 | 2.79% | 0.00% |
| Jan. 22, 2026 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 1882 | $18.15 | 145,355.0000 | 54,563,864 | 1.28% | 0.00% |
| Jan. 22, 2026 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 1882 | $3.79 | 147,237.0000 | 54,563,864 | 1.29% | 0.00% |
| Jan. 22, 2026 | Cohlhepp Ryan | President and COO | S | Common Stock | 3828 | $18.10 | 210,164.0000 | 54,563,864 | 1.79% | 0.01% |
| Jan. 15, 2026 | Cohlhepp Ryan | President and COO | S | Common Stock | 149 | $18.02 | 213,992.0000 | 54,563,864 | 0.07% | 0.00% |
| Dec. 26, 2025 | Cohlhepp Ryan | President and COO | M | Common Stock | 25000 | $4.44 | 214,141.0000 | 54,563,864 | 13.22% | 0.05% |
| Dec. 26, 2025 | Cohlhepp Ryan | President and COO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 39,909.0000 | 54,563,864 | 38.52% | 0.05% |
| Dec. 26, 2025 | Raben David | Chief Medical Officer | M | Common Stock | 19789 | $3.79 | 55,286.0000 | 54,563,864 | 55.75% | 0.04% |
| Dec. 26, 2025 | Raben David | Chief Medical Officer | M | Stock Option (Right to Buy) | 19789 | $0.00 | 98,987.0000 | 54,563,864 | 16.66% | 0.04% |
| Dec. 22, 2025 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 9200 | $3.79 | 154,555.0000 | 54,563,864 | 6.33% | 0.02% |
| Dec. 22, 2025 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 9200 | $0.00 | 88,984.0000 | 54,563,864 | 9.37% | 0.02% |
| Dec. 22, 2025 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 9200 | $18.31 | 145,355.0000 | 54,563,864 | 5.95% | 0.02% |
| Dec. 16, 2025 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 29500 | $0.00 | 565,512.0000 | 54,563,864 | 4.96% | 0.05% |
| Dec. 16, 2025 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 29500 | $5.45 | 339,392.0000 | 54,563,864 | 9.52% | 0.05% |
| Dec. 15, 2025 | Cohlhepp Ryan | President and COO | M | Stock Option (Right to Buy) | 8000 | $0.00 | 141,334.0000 | 54,563,864 | 5.36% | 0.01% |
| Dec. 15, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 8000 | $18.68 | 193,641.0000 | 54,563,864 | 3.97% | 0.01% |
| Dec. 15, 2025 | Cohlhepp Ryan | President and COO | M | Common Stock | 8000 | $3.79 | 201,641.0000 | 54,563,864 | 4.13% | 0.01% |
| Dec. 15, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 4500 | $18.68 | 189,141.0000 | 54,563,864 | 2.32% | 0.01% |
| Nov. 21, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 4500 | $18.05 | 193,641.0000 | 54,563,864 | 2.27% | 0.01% |
| Nov. 25, 2025 | Raben David | Chief Medical Officer | M | Stock Option (Right to Buy) | 906 | $0.00 | 69,413.0000 | 54,563,864 | 1.29% | 0.00% |
| Nov. 25, 2025 | Raben David | Chief Medical Officer | M | Stock Option (Right to Buy) | 4594 | $0.00 | 118,776.0000 | 54,563,864 | 3.72% | 0.01% |
| Nov. 24, 2025 | Raben David | Chief Medical Officer | M | Stock Option (Right to Buy) | 5500 | $0.00 | 123,370.0000 | 54,563,864 | 4.27% | 0.01% |
| Nov. 25, 2025 | Raben David | Chief Medical Officer | S | Common Stock | 906 | $18.84 | 35,497.0000 | 54,563,864 | 2.49% | 0.00% |
| Nov. 25, 2025 | Raben David | Chief Medical Officer | M | Common Stock | 906 | $3.79 | 36,403.0000 | 54,563,864 | 2.55% | 0.00% |
| Nov. 25, 2025 | Raben David | Chief Medical Officer | S | Common Stock | 4594 | $18.84 | 35,497.0000 | 54,563,864 | 11.46% | 0.01% |
| Nov. 25, 2025 | Raben David | Chief Medical Officer | M | Common Stock | 4594 | $3.79 | 40,091.0000 | 54,563,864 | 12.94% | 0.01% |
| Nov. 24, 2025 | Raben David | Chief Medical Officer | S | Common Stock | 5500 | $18.45 | 35,497.0000 | 54,563,864 | 13.42% | 0.01% |
| Nov. 24, 2025 | Raben David | Chief Medical Officer | M | Common Stock | 5500 | $3.79 | 40,997.0000 | 54,563,864 | 15.49% | 0.01% |
| Nov. 24, 2025 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 41163 | $0.00 | 236,107.0000 | 54,563,864 | 14.85% | 0.08% |
| Nov. 24, 2025 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 41163 | $18.86 | 309,892.0000 | 54,563,864 | 11.73% | 0.08% |
| Nov. 24, 2025 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 41163 | $3.79 | 351,055.0000 | 54,563,864 | 13.28% | 0.08% |
| Nov. 21, 2025 | Cohlhepp Ryan | President and COO | M | Stock Option (Right to Buy) | 8000 | $0.00 | 149,334.0000 | 54,563,864 | 5.08% | 0.01% |
| Nov. 21, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 8000 | $18.05 | 198,141.0000 | 54,563,864 | 3.88% | 0.01% |
| Nov. 21, 2025 | Cohlhepp Ryan | President and COO | M | Common Stock | 8000 | $3.79 | 206,141.0000 | 54,563,864 | 4.04% | 0.01% |
| Nov. 24, 2025 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 17795 | $0.00 | 98,184.0000 | 54,563,864 | 15.34% | 0.03% |
| Nov. 21, 2025 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 605 | $0.00 | 115,979.0000 | 54,563,864 | 0.52% | 0.00% |
| Nov. 24, 2025 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 17795 | $18.55 | 145,355.0000 | 54,563,864 | 10.91% | 0.03% |
| Nov. 24, 2025 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 17795 | $3.79 | 163,150.0000 | 54,563,864 | 12.24% | 0.03% |
| Nov. 21, 2025 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 605 | $18.15 | 145,355.0000 | 54,563,864 | 0.41% | 0.00% |
| Nov. 21, 2025 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 605 | $3.79 | 145,960.0000 | 54,563,864 | 0.42% | 0.00% |
| Oct. 16, 2025 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 24103 | $0.00 | 277,270.0000 | 54,563,864 | 8.00% | 0.04% |
| Oct. 16, 2025 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 24103 | $18.83 | 309,892.0000 | 54,563,864 | 7.22% | 0.04% |
| Oct. 16, 2025 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 24103 | $3.79 | 333,995.0000 | 54,563,864 | 7.78% | 0.04% |
| Oct. 15, 2025 | Cohlhepp Ryan | President and COO | M | Common Stock | 8000 | $3.79 | 210,641.0000 | 54,563,864 | 3.95% | 0.01% |
| Oct. 15, 2025 | Cohlhepp Ryan | President and COO | M | Stock Option (Right to Buy) | 8000 | $0.00 | 157,334.0000 | 54,563,864 | 4.84% | 0.01% |
| Oct. 15, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 8000 | $18.16 | 202,641.0000 | 54,563,864 | 3.80% | 0.01% |
| Oct. 15, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 4500 | $18.16 | 198,141.0000 | 54,563,864 | 2.22% | 0.01% |
| Oct. 13, 2025 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 11445 | $3.79 | 321,337.0000 | 54,563,864 | 3.69% | 0.02% |
| Oct. 13, 2025 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 11445 | $18.92 | 309,892.0000 | 54,563,864 | 3.56% | 0.02% |
| Oct. 15, 2025 | Mazumdar Claire | Chief Executive Officer | M | Common Stock | 13289 | $3.79 | 323,181.0000 | 54,563,864 | 4.29% | 0.02% |
| Oct. 15, 2025 | Mazumdar Claire | Chief Executive Officer | S | Common Stock | 13289 | $18.84 | 309,892.0000 | 54,563,864 | 4.11% | 0.02% |
| Oct. 13, 2025 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 11445 | $0.00 | 314,662.0000 | 54,563,864 | 3.51% | 0.02% |
| Oct. 15, 2025 | Mazumdar Claire | Chief Executive Officer | M | Stock Option (Right to Buy) | 13289 | $0.00 | 301,373.0000 | 54,563,864 | 4.22% | 0.02% |
| Oct. 9, 2025 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 6415 | $3.79 | 151,770.0000 | 54,563,864 | 4.41% | 0.01% |
| Oct. 9, 2025 | Raben David | Chief Medical Officer | M | Common Stock | 22000 | $3.79 | 57,497.0000 | 54,563,864 | 61.98% | 0.04% |
| Oct. 9, 2025 | Raben David | Chief Medical Officer | S | Common Stock | 22000 | $18.45 | 35,497.0000 | 54,563,864 | 38.26% | 0.04% |
| Oct. 9, 2025 | Raben David | Chief Medical Officer | M | Stock Option (Right to Buy) | 22000 | $0.00 | 128,870.0000 | 54,563,864 | 14.58% | 0.04% |
| Oct. 9, 2025 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 6415 | $18.23 | 145,355.0000 | 54,563,864 | 4.23% | 0.01% |
| Oct. 9, 2025 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 6415 | $0.00 | 116,584.0000 | 54,563,864 | 5.22% | 0.01% |
| Oct. 6, 2025 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 6514 | $3.79 | 151,869.0000 | 54,563,864 | 4.48% | 0.01% |
| Oct. 7, 2025 | Cohlhepp Ryan | President and COO | M | Stock Option (Right to Buy) | 8000 | $0.00 | 165,334.0000 | 54,563,864 | 4.62% | 0.01% |
| Oct. 6, 2025 | Cohlhepp Ryan | President and COO | M | Stock Option (Right to Buy) | 24000 | $0.00 | 173,334.0000 | 54,563,864 | 12.16% | 0.04% |
| Oct. 7, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 2900 | $18.06 | 202,641.0000 | 54,563,864 | 1.41% | 0.01% |
| Oct. 7, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 8000 | $18.06 | 205,541.0000 | 54,563,864 | 3.75% | 0.01% |
| Oct. 7, 2025 | Cohlhepp Ryan | President and COO | M | Common Stock | 8000 | $3.79 | 213,541.0000 | 54,563,864 | 3.89% | 0.01% |
| Oct. 6, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 15600 | $18.06 | 205,541.0000 | 54,563,864 | 7.05% | 0.03% |
| Oct. 6, 2025 | Cohlhepp Ryan | President and COO | S | Common Stock | 24000 | $18.06 | 221,141.0000 | 54,563,864 | 9.79% | 0.04% |
| Oct. 6, 2025 | Cohlhepp Ryan | President and COO | M | Common Stock | 24000 | $3.79 | 245,141.0000 | 54,563,864 | 10.85% | 0.04% |
| Oct. 8, 2025 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 5627 | $0.00 | 122,999.0000 | 54,563,864 | 4.37% | 0.01% |
| Oct. 7, 2025 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 18244 | $0.00 | 128,626.0000 | 54,563,864 | 12.42% | 0.03% |
| Oct. 6, 2025 | Hyep Ivan | Chief Financial Officer | M | Stock Option (Right to Buy) | 6514 | $0.00 | 146,870.0000 | 54,563,864 | 4.25% | 0.01% |
| Oct. 8, 2025 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 5627 | $18.21 | 145,355.0000 | 54,563,864 | 3.73% | 0.01% |
| Oct. 8, 2025 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 5627 | $3.79 | 150,982.0000 | 54,563,864 | 3.87% | 0.01% |
| Oct. 7, 2025 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 18244 | $18.22 | 145,355.0000 | 54,563,864 | 11.15% | 0.03% |
| Oct. 7, 2025 | Hyep Ivan | Chief Financial Officer | M | Common Stock | 18244 | $3.79 | 163,599.0000 | 54,563,864 | 12.55% | 0.03% |
| Oct. 6, 2025 | Hyep Ivan | Chief Financial Officer | S | Common Stock | 6514 | $18.17 | 145,355.0000 | 54,563,864 | 4.29% | 0.01% |
| Sept. 29, 2025 | Meisner Lara | Chief Legal Officer | S | Common Stock | 33807 | $14.75 | 0.0000 | 16,805,524,000 | 100.00% | 0.00% |
| Sept. 29, 2025 | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 33807 | $0.00 | 101,423.0000 | 16,805,524,000 | 25.00% | 0.00% |
| Sept. 29, 2025 | Meisner Lara | Chief Legal Officer | M | Common Stock | 33807 | $9.24 | 33,807.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| Sept. 15, 2025 | Meisner Lara | Chief Legal Officer | S | Common Stock | 15829 | $11.49 | 0.0000 | 16,805,524,000 | 100.00% | 0.00% |
| Sept. 15, 2025 | Meisner Lara | Chief Legal Officer | M | Common Stock | 15829 | $5.45 | 15,829.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| Sept. 15, 2025 | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 9744 | $0.00 | 87,699.0000 | 16,805,524,000 | 10.00% | 0.00% |
| Sept. 15, 2025 | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 6085 | $0.00 | 54,769.0000 | 16,805,524,000 | 10.00% | 0.00% |
| June 16, 2025 | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 9744 | $0.00 | 97,443.0000 | 16,805,524,000 | 9.09% | 0.00% |
| June 16, 2025 | Meisner Lara | Chief Legal Officer | S | Common Stock | 15829 | $10.43 | 0.0000 | 16,805,524,000 | 100.00% | 0.00% |
| June 16, 2025 | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 6085 | $0.00 | 60,854.0000 | 16,805,524,000 | 9.09% | 0.00% |
| June 16, 2025 | Meisner Lara | Chief Legal Officer | M | Common Stock | 15829 | $5.45 | 15,829.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 9, 2025 | Bowden Christopher | Director | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 9, 2025 | Simson Jake | Director | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 9, 2025 | Robertson Scott M. | Director | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 9, 2025 | LONBERG NILS | Director | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 9, 2025 | POWELL MICHAEL | Director | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 9, 2025 | Mazumdar-Shaw Kiran | Director | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 9, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 9, 2025 | Haviland Kate | Director | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| March 14, 2025 | Meisner Lara | Chief Legal Officer | S | Common Stock | 48526 | $12.69 | 30,620.0000 | 16,805,524,000 | 61.31% | 0.00% |
| March 14, 2025 | Meisner Lara | Chief Legal Officer | M | Common Stock | 79146 | $5.45 | 79,145.0000 | 16,805,524,000 | 0.00% | 0.00% |
| March 14, 2025 | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 30246 | $0.00 | 67,119.0000 | 16,805,524,000 | 31.06% | 0.00% |
| March 14, 2025 | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 48720 | $0.00 | 107,187.0000 | 16,805,524,000 | 31.25% | 0.00% |
| March 14, 2025 | Meisner Lara | Chief Legal Officer | S | Common Stock | 30620 | $13.24 | 0.0000 | 16,805,524,000 | 100.00% | 0.00% |
| Sept. 16, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1680520 | $18.00 | 4,303,418.0000 | 580,109,000 | 64.07% | 0.29% |
| Sept. 16, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 2622898 | $0.00 | 2,622,898.0000 | 580,109,000 | 9999.99% | 0.45% |
| Sept. 16, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 10836474 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 1.87% |
| Sept. 16, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 5835024 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 1.01% |
| Sept. 16, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 12273169 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 2.12% |
| Sept. 16, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 18409755 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 3.17% |
| Sept. 16, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 152480 | $18.00 | 2,652,575.0000 | 580,109,000 | 6.10% | 0.03% |
| Sept. 16, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 2500095 | $0.00 | 2,500,095.0000 | 580,109,000 | 9999.99% | 0.43% |
| Sept. 16, 2024 | FMR LLC | Not found | C | Series C Preferred Stock | 392085 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.07% |
| Sept. 16, 2024 | FMR LLC | Not found | C | Series B Preferred Stock | 712430 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.12% |
| Sept. 16, 2024 | FMR LLC | Not found | C | Series Seed Preferred Stock | 10818 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.00% |
| Sept. 16, 2024 | FMR LLC | Not found | C | Common Stock | 392085 | $0.00 | 1,115,333.0000 | 580,109,000 | 54.21% | 0.07% |
| Sept. 16, 2024 | FMR LLC | Not found | C | Common Stock | 712430 | $0.00 | 723,248.0000 | 580,109,000 | 6585.60% | 0.12% |
| Sept. 16, 2024 | FMR LLC | Not found | C | Common Stock | 10818 | $0.00 | 10,818.0000 | 580,109,000 | 9999.99% | 0.00% |
| Sept. 16, 2024 | FIL Ltd | Not found | C | Series C Preferred Stock | 352876 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.06% |
| Sept. 16, 2024 | FIL Ltd | Not found | C | Series B Preferred Stock | 606885 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.10% |
| Sept. 16, 2024 | FIL Ltd | Not found | C | Series Seed Preferred Stock | 54092 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.01% |
| Sept. 16, 2024 | FIL Ltd | Not found | C | Common Stock | 352876 | $0.00 | 1,013,853.0000 | 580,109,000 | 53.39% | 0.06% |
| Sept. 16, 2024 | FIL Ltd | Not found | C | Common Stock | 606885 | $0.00 | 660,977.0000 | 580,109,000 | 1121.95% | 0.10% |
| Sept. 16, 2024 | FIL Ltd | Not found | C | Common Stock | 54092 | $0.00 | 54,092.0000 | 580,109,000 | 9999.99% | 0.01% |
| Sept. 16, 2024 | TPG GP A, LLC | Other | C | Series C Preferred Stock | 18121194 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 3.12% |
| Sept. 16, 2024 | TPG GP A, LLC | Other | C | Common Stock | 1960425 | $0.00 | 1,960,425.0000 | 580,109,000 | 9999.99% | 0.34% |
| Sept. 17, 2024 | Flynn James E | Other | C | Series C Preferred Stock | 7973325 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 1.37% |
| Sept. 17, 2024 | Flynn James E | Other | C | Series C Preferred Stock | 7973325 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 1.37% |
| Sept. 17, 2024 | Flynn James E | Other | P | Common Stock | 35000 | $18.00 | 1,795,174.0000 | 580,109,000 | 1.99% | 0.01% |
| Sept. 17, 2024 | Flynn James E | Other | P | Common Stock | 35000 | $18.00 | 1,795,174.0000 | 580,109,000 | 1.99% | 0.01% |
| Sept. 17, 2024 | Flynn James E | Other | C | Common Stock | 862587 | $0.00 | 1,760,174.0000 | 580,109,000 | 96.10% | 0.15% |
| Sept. 17, 2024 | Flynn James E | Other | C | Common Stock | 862587 | $0.00 | 1,760,174.0000 | 580,109,000 | 96.10% | 0.15% |
| Sept. 12, 2024 | Haviland Kate | Not found | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 580,109,000 | 9999.99% | 0.00% |
| Sept. 16, 2024 | Biocon Ltd | Not found | C | Series Seed Redeemable Convertible Preferred Stock | 40000000 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 6.90% |
| Sept. 16, 2024 | Biocon Ltd | Not found | C | Common Stock | 1080775 | $0.00 | 5,523,897.0000 | 580,109,000 | 24.32% | 0.19% |
| Sept. 16, 2024 | Biocon Ltd | Not found | C | Common Stock | 4327365 | $0.00 | 5,523,897.0000 | 580,109,000 | 361.66% | 0.75% |
| Sept. 12, 2024 | Simson Jake | Not found | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 580,109,000 | 9999.99% | 0.00% |
| Sept. 12, 2024 | LONBERG NILS | Not found | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 580,109,000 | 9999.99% | 0.00% |
| Sept. 12, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 580,109,000 | 9999.99% | 0.00% |
| Sept. 16, 2024 | Mazumdar-Shaw Kiran | Not found | C | Series Seed Redeemable Convertible Preferred Stock | 40000000 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 6.90% |
| Sept. 16, 2024 | Mazumdar-Shaw Kiran | Not found | C | Series Seed Redeemable Convertible Preferred Stock | 4000000 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.69% |
| Sept. 16, 2024 | Mazumdar-Shaw Kiran | Not found | C | Series Seed Redeemable Convertible Preferred Stock | 9990144 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 1.72% |
| Sept. 16, 2024 | Mazumdar-Shaw Kiran | Not found | C | Series Seed Redeemable Convertible Preferred Stock | 3000000 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.52% |
| Sept. 12, 2024 | Mazumdar-Shaw Kiran | Not found | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 580,109,000 | 9999.99% | 0.00% |
| Sept. 16, 2024 | Mazumdar-Shaw Kiran | Not found | C | Common Stock | 432736 | $0.00 | 6,281,185.0000 | 580,109,000 | 7.40% | 0.07% |
| Sept. 16, 2024 | Mazumdar-Shaw Kiran | Not found | C | Common Stock | 324552 | $0.00 | 6,281,185.0000 | 580,109,000 | 5.45% | 0.06% |
| Sept. 16, 2024 | Mazumdar-Shaw Kiran | Not found | C | Common Stock | 1080775 | $0.00 | 6,281,185.0000 | 580,109,000 | 20.78% | 0.19% |
| Sept. 16, 2024 | Mazumdar-Shaw Kiran | Not found | C | Common Stock | 4327365 | $0.00 | 6,281,185.0000 | 580,109,000 | 221.48% | 0.75% |
| Sept. 12, 2024 | Robertson Scott M. | Not found | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 580,109,000 | 9999.99% | 0.00% |
| Sept. 16, 2024 | Biocon Ltd | Not found | C | Series Seed Redeemable Convertible Preferred Stock | 9990144 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 1.72% |